Piotr Czempik: Anti-Xa-Guided Enoxaparin Prophylaxis in Extreme Obesity
Piotr Czempik, Chair of Department of Anesthesiology and Intensive Care at Medical University of Silesia, shared on LinkedIn about recent article he and his colleague co-authored, published in Journal of Transfusion Medicine and Hemostasis, adding:
”How to provide safe and effective antithrombotic prophylaxis in extremely obese patients?
Happy to share our latest case report addressing this challenging critical care issue.
What the paper covers:
Patients >150–200 kg often fail to reach target anti‑Xa levels with standard low-molecular-weight heparin (LMWH) dosing.
In our 200‑kg ICU patient, we implemented a fully individualized strategy using:
- weight‑based enoxaparin dosing
- twice‑daily administration
- serial anti‑Xa monitoring
- additional ROTEM analysis for anticoagulation interpretation
- dynamic dose adjustment to maintain intermediate‑intensity antithrombotic prophylaxis
The result: effective VTE prevention with no bleeding events, demonstrating the value of personalized anticoagulation in this high‑risk population.
Key insight:
An initial enoxaparin dose of 0.3 mg/kg SC BID, followed by anti‑Xa–guided adjustment, may offer a rational and safer approach for ICU patients with extreme obesity.”
Title: Optimizing prophylactic low-molecular-weight heparin anticoagulation in a 200-kg ICU patient: a case report
Authors: Piotr Filip Czempik, Dariusz Bednarski
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 20:00Ahmed Alaqab: Proud to Share Our Systematic Review on Medication Adherence After Switching to DOACs
-
Oct 31, 2026, 19:57Katarzyna Kniola: Proud to Share My First Scientific Publication in Haemophilia
-
Oct 31, 2026, 19:53Mohammad Vahabi: Exploring the Role of JAK Inhibitors in Urticarial Vasculitis
-
Oct 31, 2026, 19:50Agata Sobczynska-Malefora: How Age and Ethnicity Influence Active Vitamin B12 and MMA Levels
-
Oct 31, 2026, 19:47David Shoultz: Running for MPN Research at the ASH Annual Meeting
-
Oct 31, 2026, 19:40Andreas Calatzis: Revisiting a Widely Cited Study on Preoperative Screening for Primary Hemostasis Disorders
-
Oct 31, 2026, 19:40How Antiseizure Medication Selection May Influence DOAC Safety in Epilepsy – JAMA Neurology
-
Oct 31, 2026, 19:35Alejandro González Veliz: Balancing Ischemic Protection and Bleeding Risk in Antiplatelet Management
-
Oct 31, 2026, 19:29Sascha David: Therapeutic Plasma Exchange Associated with Lower 90 Day Mortality in Streptococcal Septic Shock